prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2018
-
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
Cytometry Part B ( Clinical cytometry), year: 2018, volume: 94, edition: 1, DOI
-
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
Leukemia, year: 2018, volume: 32, edition: 9, DOI
-
Stanovení kauzálních variant u dědičných trombocytopenií
Year: 2018, type: Conference abstract
-
Terapie chronické lymfocytární leukemie v roce 2018
Transfuze a hematologie dnes, year: 2018
-
Tracking minor clones in chronic lymphocytic leukemia using high-throughput immunoprofiling
Year: 2018, type: Conference abstract
-
Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling
Year: 2018, type: Conference abstract
-
Tumour-reactive gamma-delta T cells targeting the EphA2 receptor in B- cell CLL
Year: 2018, type: Conference abstract
-
Unexpected role of Aurora kinase inhibitors in CD20 expression
Year: 2018, type: Conference abstract
-
Úvodní slovo, výroční zpráva ČS CLL a databáze CLLEAR v roce 2018
Year: 2018, type:
-
Uvolnění buněk chronické lymfocytární leukemie z lymfatického systému do periferie po aplikaci rituximabu
Year: 2018, type: Conference abstract